LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

HSG Holding Ltd's Holding History (CIK: 0001470766)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 3,045,997 Value ($000) $1,462 Avg Close — Range —
Q4 2024
Shares 3,045,997 Value ($000) $1,736 Avg Close — Range —
Q3 2024
Shares 3,045,997 Value ($000) $3,412 Avg Close — Range —
Q2 2024
Shares 3,045,997 Value ($000) $4,995 Avg Close — Range —
Q1 2024
Shares 3,045,997 Value ($000) $7,432 Avg Close — Range —
Q4 2023
Shares 3,045,997 Value ($000) $6,397 Avg Close — Range —
Q3 2023
Shares 3,045,997 Value ($000) $4,478 Avg Close — Range —
Q2 2023
Shares 3,045,997 Value ($000) $9,686 Avg Close — Range —
Q1 2023
Shares 3,045,997 Value ($000) $7,189 Avg Close — Range —
Q4 2022
Shares 3,045,997 Value ($000) $10,570 Avg Close — Range —
Q3 2022
Shares 3,045,997 Value ($000) $22,327 Avg Close — Range —
Q2 2022
Shares 3,045,997 Value ($000) $19,860 Avg Close — Range —
Q1 2022
Shares 3,045,997 Value ($000) $15,382 Avg Close — Range —
Q4 2021
Shares 3,045,997 Value ($000) $23,576 Avg Close — Range —
Q3 2021
Shares 3,045,997 Value ($000) $45,081 Avg Close — Range —
Q2 2021
Shares 2,436,798 Value ($000) $39,574 Avg Close — Range —